The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla’s patented Resonator system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
Pico-Tesla’s Magneceutical Therapy involves the use of low-level electromagnetic field (EMF) applied by a specially designed device the Resonator, invented by Jerry Jacobson, along with proprietary therapeutic protocols intended to improve a number of the signs and symptoms of fibromyalgia.
The protocols also improve other disorders and diseases like atrial fibrillation, Parkinson’s disease, Alzheimer’s disease and osteoarthritis.
Pico-Tesla CEO Allen Braswell said they are excited about expanding the clinical indications for Magneceutical Therapy, and pleased to have Trevino coordinating their pilot study to establish the clinical potential of Magneceutical Therapy for fibromyalgia patients.
